Find a Clinical Trial
Filter
ORCHID
Nasal polyps
All genders
18-75
Recruiting now
Department of Medicine, Division of Rheumatology
SBT777101-01
Arthritis
All genders
18-70
Recruiting now
Department of Medicine, Division of Rheumatology
Organogenesis Knee OA
Osteoarthritis
All genders
18+
Recruiting now
Department of Medicine, Division of Rheumatology
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer (OPERA-01)
Breast cancer, Locally advanced and metastatic breast cancer
All genders
18+
Recruiting now
Cancer Center
Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin (VOLGA)
Bladder cancer
All genders
18+
Recruiting now
Department of Medicine, Cancer Center
RA-PROPR
Rheumatoid arthritis
All genders
18+
Recruiting now
Department of Medicine, Division of Rheumatology
BIPI
Systemic sclerosis
All genders
18+
Recruiting now
Department of Medicine, Division of Rheumatology
A Study of Dato-DXd Versus Investigator's Choice Chemotherapy
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
Breast Cancer Database
Breast cancer
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy (CAMBRIA-1)
All genders
18+
Recruiting now
Cancer Center